Hemispherx BioPharma (HEB) News Today $6.70 -1.68 (-20.05%) As of 06/13/2025 Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsBuy This Stock HEB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Hemispherx BioPharma (NYSEAMERICAN:HEB) Stock Passes Above 200-Day Moving Average - Time to Sell?September 23, 2025 | americanbankingnews.comHamilton ETFs Launches Hamilton Canadian Financials Index ETFJanuary 20, 2025 | businesswire.comH-E-B’s affordable grocery chain Joe V’s Smart Shop is coming to IrvingAugust 10, 2024 | dallasnews.comDHemispherx Biopharma earnings preview: what Wall Street is expectingMay 15, 2024 | markets.businessinsider.comH-E-B hosting hiring fairsJanuary 7, 2024 | cbsnews.comH-E-B bets on loyal customers as it expands affordable Joe V’s storesOctober 3, 2023 | chron.comH-E-B enters the film world with a five-part docuseries covering Texas parks and wildlifeAugust 28, 2023 | chron.comH-E-B opens doors to new Georgetown grocery storeJuly 1, 2023 | bizjournals.comHemispherx's Ampligen Dealt FDA BlowJune 27, 2023 | thestreet.comYS Biopharma Down 38%; Reports Favorable Covid-19 Vaccine ResultsMarch 29, 2023 | marketwatch.comFirst Wave BioPharma Shares Rise 9% After Dosing First Patient With AdrulipaseMarch 11, 2023 | marketwatch.comH-E-B plans to hire 700 for its McKinney storeFebruary 26, 2023 | dallasnews.comDH-E-B worker starts petition over grocer’s sick policy after testing positive for COVIDJanuary 26, 2023 | dallasnews.comDH-E-B starts its plans for a second Frisco store near Little ElmJanuary 12, 2023 | dallasnews.comDH-E-B working on plans for a second Frisco store — this time near Little ElmJanuary 12, 2023 | bizjournals.comAre you ready for another H-E-B? Fort Worth location will break ground soonOctober 29, 2022 | bizjournals.comHere's everything you need to know about H-E-B Frisco, which opens todaySeptember 23, 2022 | bizjournals.comEbola Outbreak Puts the Spotlight on 10 Biotech CompaniesSeptember 17, 2022 | thestreet.comHemispherx CEO Spills Ampligen Beans to Stock Cheerleader: BioBuzzAugust 24, 2022 | thestreet.comOrganic Strawberries Tied to a Hepatitis A Outbreak Are Being Recalled Across North AmericaMay 31, 2022 | news.yahoo.com Get Hemispherx BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HEB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HEB Media Mentions By Week HEB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HEB News Sentiment▼0.000.87▲Average Medical News Sentiment HEB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HEB Articles This Week▼00▲HEB Articles Average Week Get the Latest News and Ratings for HEB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Hemispherx BioPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies HYPD News Today IBIO News Today PHGE News Today BRTX News Today PHXM News Today ADIL News Today SXTPW News Today AGNPF News Today AKBLF News Today DRTSW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:HEB) was last updated on 10/2/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Biotech has a clinical approach that intrigues investorsThis biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. ...i2i Marketing Group, LLC | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemispherx BioPharma, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemispherx BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
